-
CLINICAL TRIAL EVIDENCE SUPPORTING FDA APPROVAL OF NOVEL AGENTS IN 2024
Mar 18, 2026, 21:38 PM -
PERIOPERATIVE COST-EFFECTIVENESS OF PARTIAL NEPHRECTOMY TECHNIQUES FOR RENAL CELL CARCINOMA IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
PROVISIONAL PRICING IN MEDICINE POLICY: GLOBAL BENCHMARKING
Mar 18, 2026, 21:38 PM -
TREATMENT COMPARISON FOR HTA. USING NICE AS AN EXAMPLE, DOES CURRENT USE REFLECT THE EVOLUTION FROM ANCHORED METHODS TO COMPLEX MODELS, AND ADJUSTMENT TECHNIQUES?
Mar 18, 2026, 21:38 PM -
ECONOMIC AND EPIDEMIOLOGICAL BURDEN OF DIABETES IN MAGHREB COUNTRIES: ALGERIA, TUNISIA, AND MOROCCO
Mar 18, 2026, 21:38 PM -
RENEWAL PATHWAYS AND HEALTH INSURANCE COVERAGE RETENTION UNDER GHANA’S NHIS: IMPLICATIONS FOR UNIVERSAL HEALTH COVERAGE
Mar 18, 2026, 21:38 PM -
IMPACT OF MEDICATION CLUSTERS ON POST-DISCHARGE ADVERSE DRUG EVENTS AND HEALTHCARE UTILIZATION AMONG OLDER ADULTS
Mar 18, 2026, 21:38 PM -
CHANGES IN BREAST CANCER SCREENING PREVALENCE FOLLOWING UPDATED USPSTF MAMMOGRAPHY GUIDELINES: DESCRIPTIVE ANALYSIS USING MARKETSCAN TREATMENT PATHWAYS
Mar 18, 2026, 21:38 PM -
COMPARING THECOSTEFFECTIVENESS OFONSITEBUPRENORPHINE TREATMENT VERSUSTREATMENT FACILITY REFERRALATHARM REDUCTION AGENCIES
Mar 18, 2026, 21:38 PM -
PHYSICAL AND MENTAL HEALTH STATUS AND PRODUCTIVITY LOSS ASSOCIATED WITH MIGRAINE: A REAL-WORLD EVIDENCE ANALYSIS USING A NATIONALLY REPRESENTATIVE US COHORT
Mar 18, 2026, 21:38 PM -
PREDICTING PROSTATE CANCER INCIDENCE USING A LARGE, NATIONAL U.S. ELECTRONIC HEALTH RECORDS (EHR) DATABASE
Mar 18, 2026, 21:38 PM -
HOSPITALIZATION COSTS ASSOCIATED WITH 30-DAY UNPLANNED READMISSIONS AND POTENTIALLY PREVENTABLE READMISSIONS IN US OLDER PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Mar 18, 2026, 21:38 PM -
ADVANCING EQUITY IN PROSTATE CANCER RESEARCH: STRATEGY AND OUTCOMES FROM A PROSPECTIVE ENROLLMENT INITIATIVE
Mar 18, 2026, 21:38 PM -
ASSESSING THE CONCORDANCE BETWEEN SELF-REPORTED NICOTINE PRODUCT USE AND EMR DIAGNOSIS CODES IN THE ALL OF US RESEARCH PROGRAM
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND TREATMENT PATTERNS OF THRYOID EYE DISEASE IN SPAIN: POPULATION-BASED REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COST ANALYSIS OF WHOLE-BODY PET-CT SCAN USING TIME-DRIVEN ACTIVITY-BASED COSTING AT A GOVERNMENT CANCER HOSPITAL IN NORTH INDIA
Mar 18, 2026, 21:38 PM -
COMPARING OUTCOME MODELING STRATEGIES FOR ZERO-INFLATED ABSENTEEISM IN REAL-WORLD DATA: IMPLICATIONS FOR INFERENCE ON ANXIETY SEVERITY
Mar 18, 2026, 21:38 PM -
TRANSPARENCY OF CHARLSON COMORBIDITY INDEX (CCI) CODE DEFINITIONS IN REAL-WORLD RESEARCH: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN CISPLATIN ELIGIBLE VERSUS CISPLATIN INELIGIBLE MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH INTENT FOR RESECTION: A MULTICOUNTRY RETROSPECTIVE CHART REVIEW IN EUROPE
Mar 18, 2026, 21:38 PM
